 | • レポートコード：MRC2102QY14805 • 出版社/出版日：QYResearch / 2021年1月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、147ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品、医療 |
| Single User | ￥600,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥900,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,200,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYリサーチ社の本調査レポートでは、世界の治療用酵素市場について種類別（注射剤、経口、局所）、用途別（ゴーシェ病、MPS病、胃腸疾患、その他）、地域別（米国、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・治療用酵素市場の概要 ・世界の主要地域別治療用酵素市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界の治療用酵素市場規模2015-2026：種類別（注射剤、経口、局所） ・世界の治療用酵素市場規模2015-2026：用途別（ゴーシェ病、MPS病、胃腸疾患、その他） ・治療用酵素の米国市場規模2015-2020 ・治療用酵素のヨーロッパ市場規模2015-2020 ・治療用酵素の中国市場規模2015-2020 ・治療用酵素の日本市場規模2015-2020 ・治療用酵素の東南アジア市場規模2015-2020 ・治療用酵素のインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 ・治療用酵素の製造コスト分析 ・販売チャネル、流通業者、顧客 ・治療用酵素の市場動向・機会・課題 ・調査の結論 |
Therapeutic enzymes have a broad variety of specific uses, Oncolytics, Anticoagulants, Thrombolytics, Replacements for metabolic deficiencies, Digestive aids, Metabolic storage disorders, etc. Miscellaneous enzymes of diverse function.
Sanofi was the global greatest company in Therapeutic Enzymes industry, with the revenue market Share of 33% in 2018, followed by BioMarin, AbbVie , Shire, Alexion, Horizon Pharma, Allergan, Johnson & Johnson, Recordati Rare Diseases, Pfizer, Vivus, Digestive Care, Leadiant Biosciences.
Market Analysis and Insights: Global Therapeutic Enzymes Market
The global Therapeutic Enzymes market size is projected to reach US$ 20180 million by 2026, from US$ 10170 million in 2020, at a CAGR of 12.1% during 2021-2026.
Global Therapeutic Enzymes Scope and Market Size
The global Therapeutic Enzymes market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Therapeutic Enzymes market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2015-2026.
Segment by Type, the Therapeutic Enzymes market is segmented into
Injectable
Oral
Topical
Oral had the biggest market share of 94% in 2018.
Segment by Application, the Therapeutic Enzymes market is segmented into
Gaucher Disease
MPS Disease
Gastrointestinal Diseases
Others
MPS Disease is the greatest segment of Therapeutic Enzymes application, with a share of 22% in 2018.
The Therapeutic Enzymes market is analysed and market size information is provided by regions (countries). Segment by Application, the Therapeutic Enzymes market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Therapeutic Enzymes Market Share Analysis
Therapeutic Enzymes market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Therapeutic Enzymes business, the date to enter into the Therapeutic Enzymes market, Therapeutic Enzymes product introduction, recent developments, etc.
The major vendors covered:
Sanofi
BioMarin
AbbVie
Shire
Alexion
Horizon Pharma
Allergan
Johnson & Johnson
Recordati Rare Diseases
Pfizer
Vivus
Digestive Care
Leadiant Biosciences
1 Therapeutic Enzymes Market Overview
1.1 Therapeutic Enzymes Product Scope
1.2 Therapeutic Enzymes Segment by Type
1.2.1 Global Therapeutic Enzymes Sales by Type (2020-2026)
1.2.2 Injectable
1.2.3 Oral
1.2.4 Topical
1.3 Therapeutic Enzymes Segment by Application
1.3.1 Global Therapeutic Enzymes Sales Comparison by Application (2020-2026)
1.3.2 Gaucher Disease
1.3.3 MPS Disease
1.3.4 Gastrointestinal Diseases
1.3.5 Others
1.4 Therapeutic Enzymes Market Estimates and Forecasts (2015-2026)
1.4.1 Global Therapeutic Enzymes Sales Growth Rate (2015-2026)
1.4.2 Global Therapeutic Enzymes Revenue and Growth Rate (2015-2026)
1.4.3 Global Therapeutic Enzymes Price Trends (2015-2026)
2 Therapeutic Enzymes Estimate and Forecast by Region
2.1 Global Therapeutic Enzymes Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Therapeutic Enzymes Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Therapeutic Enzymes Sales Market Share by Region (2015-2020)
2.2.2 Global Therapeutic Enzymes Revenue Market Share by Region (2015-2020)
2.3 Global Therapeutic Enzymes Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Therapeutic Enzymes Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Therapeutic Enzymes Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Therapeutic Enzymes Estimates and Projections (2015-2026)
2.4.2 Europe Therapeutic Enzymes Estimates and Projections (2015-2026)
2.4.3 China Therapeutic Enzymes Estimates and Projections (2015-2026)
2.4.4 Japan Therapeutic Enzymes Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Therapeutic Enzymes Estimates and Projections (2015-2026)
2.4.6 India Therapeutic Enzymes Estimates and Projections (2015-2026)
3 Global Therapeutic Enzymes Competition Landscape by Players
3.1 Global Top Therapeutic Enzymes Players by Sales (2015-2020)
3.2 Global Top Therapeutic Enzymes Players by Revenue (2015-2020)
3.3 Global Therapeutic Enzymes Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Therapeutic Enzymes as of 2019)
3.4 Global Therapeutic Enzymes Average Price by Company (2015-2020)
3.5 Manufacturers Therapeutic Enzymes Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Therapeutic Enzymes Players (Opinion Leaders)
4 Global Therapeutic Enzymes Market Size by Type
4.1 Global Therapeutic Enzymes Historic Market Review by Type (2015-2020)
4.1.1 Global Therapeutic Enzymes Sales Market Share by Type (2015-2020)
4.1.2 Global Therapeutic Enzymes Revenue Market Share by Type (2015-2020)
4.1.3 Global Therapeutic Enzymes Price by Type (2015-2020)
4.2 Global Therapeutic Enzymes Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Therapeutic Enzymes Sales Forecast by Type (2021-2026)
4.2.2 Global Therapeutic Enzymes Revenue Forecast by Type (2021-2026)
4.2.3 Global Therapeutic Enzymes Price Forecast by Type (2021-2026)
5 Global Therapeutic Enzymes Market Size by Application
5.1 Global Therapeutic Enzymes Historic Market Review by Application (2015-2020)
5.1.1 Global Therapeutic Enzymes Sales Market Share by Application (2015-2020)
5.1.2 Global Therapeutic Enzymes Revenue Market Share by Application (2015-2020)
5.1.3 Global Therapeutic Enzymes Price by Application (2015-2020)
5.2 Global Therapeutic Enzymes Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Therapeutic Enzymes Sales Forecast by Application (2021-2026)
5.2.2 Global Therapeutic Enzymes Revenue Forecast by Application (2021-2026)
5.2.3 Global Therapeutic Enzymes Price Forecast by Application (2021-2026)
6 United States Therapeutic Enzymes Market Facts & Figures
6.1 United States Therapeutic Enzymes Sales Market Share by Company (2015-2020)
6.2 United States Therapeutic Enzymes Sales Market Share by Type (2015-2020)
6.3 United States Therapeutic Enzymes Sales Market Share by Application (2015-2020)
7 Europe Therapeutic Enzymes Market Facts & Figures
7.1 Europe Therapeutic Enzymes Sales Market Share by Company (2015-2020)
7.2 Europe Therapeutic Enzymes Sales Market Share by Type (2015-2020)
7.3 Europe Therapeutic Enzymes Sales Market Share by Application (2015-2020)
8 China Therapeutic Enzymes Market Facts & Figures
8.1 China Therapeutic Enzymes Sales Market Share by Company (2015-2020)
8.2 China Therapeutic Enzymes Sales Market Share by Type (2015-2020)
8.3 China Therapeutic Enzymes Sales Market Share by Application (2015-2020)
9 Japan Therapeutic Enzymes Market Facts & Figures
9.1 Japan Therapeutic Enzymes Sales Market Share by Company (3015-3030)
9.2 Japan Therapeutic Enzymes Sales Market Share by Type (2015-2020)
9.3 Japan Therapeutic Enzymes Sales Market Share by Application (2015-2020)
10 Southeast Asia Therapeutic Enzymes Market Facts & Figures
10.1 Southeast Asia Therapeutic Enzymes Sales Market Share by Company (2015-2020)
10.2 Southeast Asia Therapeutic Enzymes Sales Market Share by Type (2015-2020)
10.3 Southeast Asia Therapeutic Enzymes Sales Market Share by Application (2015-2020)
11 India Therapeutic Enzymes Market Facts & Figures
11.1 India Therapeutic Enzymes Sales Market Share by Company (2015-2020)
11.2 India Therapeutic Enzymes Sales Market Share by Type (2015-2020)
11.3 India Therapeutic Enzymes Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Therapeutic Enzymes Business
12.1 Sanofi
12.1.1 Sanofi Corporation Information
12.1.2 Sanofi Business Overview
12.1.3 Sanofi Therapeutic Enzymes Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Sanofi Therapeutic Enzymes Products Offered
12.1.5 Sanofi Recent Development
12.2 BioMarin
12.2.1 BioMarin Corporation Information
12.2.2 BioMarin Business Overview
12.2.3 BioMarin Therapeutic Enzymes Sales, Revenue and Gross Margin (2015-2020)
12.2.4 BioMarin Therapeutic Enzymes Products Offered
12.2.5 BioMarin Recent Development
12.3 AbbVie
12.3.1 AbbVie Corporation Information
12.3.2 AbbVie Business Overview
12.3.3 AbbVie Therapeutic Enzymes Sales, Revenue and Gross Margin (2015-2020)
12.3.4 AbbVie Therapeutic Enzymes Products Offered
12.3.5 AbbVie Recent Development
12.4 Shire
12.4.1 Shire Corporation Information
12.4.2 Shire Business Overview
12.4.3 Shire Therapeutic Enzymes Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Shire Therapeutic Enzymes Products Offered
12.4.5 Shire Recent Development
12.5 Alexion
12.5.1 Alexion Corporation Information
12.5.2 Alexion Business Overview
12.5.3 Alexion Therapeutic Enzymes Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Alexion Therapeutic Enzymes Products Offered
12.5.5 Alexion Recent Development
12.6 Horizon Pharma
12.6.1 Horizon Pharma Corporation Information
12.6.2 Horizon Pharma Business Overview
12.6.3 Horizon Pharma Therapeutic Enzymes Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Horizon Pharma Therapeutic Enzymes Products Offered
12.6.5 Horizon Pharma Recent Development
12.7 Allergan
12.7.1 Allergan Corporation Information
12.7.2 Allergan Business Overview
12.7.3 Allergan Therapeutic Enzymes Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Allergan Therapeutic Enzymes Products Offered
12.7.5 Allergan Recent Development
12.8 Johnson & Johnson
12.8.1 Johnson & Johnson Corporation Information
12.8.2 Johnson & Johnson Business Overview
12.8.3 Johnson & Johnson Therapeutic Enzymes Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Johnson & Johnson Therapeutic Enzymes Products Offered
12.8.5 Johnson & Johnson Recent Development
12.9 Recordati Rare Diseases
12.9.1 Recordati Rare Diseases Corporation Information
12.9.2 Recordati Rare Diseases Business Overview
12.9.3 Recordati Rare Diseases Therapeutic Enzymes Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Recordati Rare Diseases Therapeutic Enzymes Products Offered
12.9.5 Recordati Rare Diseases Recent Development
12.10 Pfizer
12.10.1 Pfizer Corporation Information
12.10.2 Pfizer Business Overview
12.10.3 Pfizer Therapeutic Enzymes Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Pfizer Therapeutic Enzymes Products Offered
12.10.5 Pfizer Recent Development
12.11 Vivus
12.11.1 Vivus Corporation Information
12.11.2 Vivus Business Overview
12.11.3 Vivus Therapeutic Enzymes Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Vivus Therapeutic Enzymes Products Offered
12.11.5 Vivus Recent Development
12.12 Digestive Care
12.12.1 Digestive Care Corporation Information
12.12.2 Digestive Care Business Overview
12.12.3 Digestive Care Therapeutic Enzymes Sales, Revenue and Gross Margin (2015-2020)
12.12.4 Digestive Care Therapeutic Enzymes Products Offered
12.12.5 Digestive Care Recent Development
12.13 Leadiant Biosciences
12.13.1 Leadiant Biosciences Corporation Information
12.13.2 Leadiant Biosciences Business Overview
12.13.3 Leadiant Biosciences Therapeutic Enzymes Sales, Revenue and Gross Margin (2015-2020)
12.13.4 Leadiant Biosciences Therapeutic Enzymes Products Offered
12.13.5 Leadiant Biosciences Recent Development
13 Therapeutic Enzymes Manufacturing Cost Analysis
13.1 Therapeutic Enzymes Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Therapeutic Enzymes
13.4 Therapeutic Enzymes Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Therapeutic Enzymes Distributors List
14.3 Therapeutic Enzymes Customers
15 Market Dynamics
15.1 Therapeutic Enzymes Market Trends
15.2 Therapeutic Enzymes Opportunities and Drivers
15.3 Therapeutic Enzymes Market Challenges
15.4 Therapeutic Enzymes Market Restraints
15.5 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Therapeutic Enzymes Sales (K Units) Growth Rate by Type (2020-2026) (US$ Million)
Table 2. Global Therapeutic Enzymes Sales (K Units) Comparison by Application (2020-2026) (US$ Million)
Table 3. Global Market Therapeutic Enzymes Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 4. Global Therapeutic Enzymes Sales (K Units) by Region (2015-2020)
Table 5. Global Therapeutic Enzymes Sales Market Share by Region (2015-2020)
Table 6. Global Therapeutic Enzymes Revenue (US$ Million) Market Share by Region (2015-2020))
Table 7. Global Therapeutic Enzymes Revenue Share by Region (2015-2020)
Table 8. Global Therapeutic Enzymes Sales (K Units) Forecast by Region (2021-2026)
Table 9. Global Therapeutic Enzymes Sales Market Share Forecast by Region (2021-2026)
Table 10. Global Therapeutic Enzymes Revenue (US$ Million) Forecast by Region (2021-2026)
Table 11. Global Therapeutic Enzymes Revenue Share Forecast by Region (2021-2026)
Table 12. Global Therapeutic Enzymes (K Units) of Key Companies (2015-2020)
Table 13. Global Therapeutic Enzymes Sales Share by Company (2015-2020)
Table 14. Global Therapeutic Enzymes Revenue (US$ Million) by Company (2015-2020)
Table 15. Global Therapeutic Enzymes Revenue Share by Company (2015-2020)
Table 16. Global Therapeutic Enzymes by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Therapeutic Enzymes as of 2019)
Table 17. Global Therapeutic Enzymes Average Price (USD/Unit) of Key Company (2015-2020)
Table 18. Manufacturers Therapeutic Enzymes Manufacturing Sites and Area Served
Table 19. Manufacturers Therapeutic Enzymes Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Main Points Interviewed from Key Therapeutic Enzymes Players
Table 22. Global Therapeutic Enzymes Sales (K Units) by Type (2015-2020)
Table 23. Global Therapeutic Enzymes Sales Share by Type (2015-2020)
Table 24. Global Therapeutic Enzymes Revenue (US$ Million) Market Share by Type (2015-2020)
Table 25. Global Therapeutic Enzymes Price (K Units) by Type (2015-2020)
Table 26. Global Therapeutic Enzymes Sales Share by Type (2021-2026)
Table 27. Global Therapeutic Enzymes Revenue (US$ Million) Market Share by Type (2021-2026)
Table 28. Global Therapeutic Enzymes Revenue Share by Type (2021-2026)
Table 29. Global Therapeutic Enzymes Price (K Units) by Type (2021-2026)
Table 30. Global Therapeutic Enzymes Sales (K Units) by Application (2015-2020)
Table 31. Global Therapeutic Enzymes Sales Share by Application (2015-2020)
Table 32. Global Therapeutic Enzymes Revenue (US$ Million) Market Share by Application (2015-2020)
Table 33. Global Therapeutic Enzymes Price (K Units) by Application (2015-2020)
Table 34. Global Therapeutic Enzymes Sales (K Units) by Application (2021-2026)
Table 35. Global Therapeutic Enzymes Sales Share by Application (2021-2026)
Table 36. Global Therapeutic Enzymes Revenue (US$ Million) Market Share by Application (2021-2026)
Table 37. Global Therapeutic Enzymes Revenue Share by Application (2021-2026)
Table 38. Global Therapeutic Enzymes Price (K Units) by Application (2021-2026)
Table 39. United States Therapeutic Enzymes Sales (K Units) by Company (2015-2020)
Table 40. United States Therapeutic Enzymes Sales Market Share by Company (2015-2020)
Table 41. United States Therapeutic Enzymes Sales (K Units) by Type (2015-2020)
Table 42. United States Therapeutic Enzymes Sales Market Share by Type (2015-2020)
Table 43. United States Therapeutic Enzymes Sales (K Units) by Application (2015-2020)
Table 44. United States Therapeutic Enzymes Sales Market Share by Application (2015-2020)
Table 45. Europe Therapeutic Enzymes Sales (K Units) by Company (2015-2020)
Table 46. Europe Therapeutic Enzymes Sales Market Share by Company (2015-2020)
Table 47. Europe Therapeutic Enzymes Sales (K Units) by Type (2015-2020)
Table 48. Europe Therapeutic Enzymes Sales Market Share by Type (2015-2020)
Table 49. Europe Therapeutic Enzymes Sales (K Units) by Application (2015-2020)
Table 50. Europe Therapeutic Enzymes Sales Market Share by Type (2015-2020)
Table 51. China Therapeutic Enzymes Sales (K Units) by Company (2015-2020)
Table 52. China Therapeutic Enzymes Sales Market Share by Company (2015-2020)
Table 53. China Therapeutic Enzymes Sales (K Units) by Type (2015-2020)
Table 54. China Therapeutic Enzymes Sales Market Share by Type (2015-2020)
Table 55. China Therapeutic Enzymes Sales (K Units) by Application (2015-2020)
Table 56. China Therapeutic Enzymes Sales Market Share by Application (2015-2020)
Table 57. Japan Therapeutic Enzymes Sales (K Units) by Company (2015-2020)
Table 58. Japan Therapeutic Enzymes Sales Market Share by Company (2015-2020)
Table 59. Japan Therapeutic Enzymes Sales (K Units) by Type (2015-2020)
Table 60. Japan Therapeutic Enzymes Sales Market Share by Type (2015-2020)
Table 61. Japan Therapeutic Enzymes Sales (K Units) by Application (2015-2020)
Table 62. Japan Therapeutic Enzymes Sales Market Share by Application (2015-2020)
Table 63. Southeast Asia Therapeutic Enzymes Sales (K Units) by Company (2015-2020)
Table 64. Southeast Asia Therapeutic Enzymes Sales Market Share by Company (2015-2020)
Table 65. Southeast Asia Therapeutic Enzymes Sales (K Units) by Type (2015-2020)
Table 66. Southeast Asia Therapeutic Enzymes Sales Market Share by Type (2015-2020)
Table 67. Southeast Asia Therapeutic Enzymes Sales (K Units) by Type (2015-2020)
Table 68. Southeast Asia Therapeutic Enzymes Sales Market Share by Application (2015-2020)
Table 69. India Therapeutic Enzymes Sales (K Units) by Company (2015-2020)
Table 70. India Therapeutic Enzymes Sales Market Share by Company (2015-2020)
Table 71. India Therapeutic Enzymes Sales (K Units) by Type (2015-2020)
Table 72. India Therapeutic Enzymes Sales Market Share by Type (2015-2020)
Table 73. India Therapeutic Enzymes Sales (K Units) by Application (2015-2020)
Table 74. India Therapeutic Enzymes Sales Market Share by Application (2015-2020)
Table 75. Sanofi Corporation Information
Table 76. Sanofi Description and Business Overview
Table 77. Sanofi Therapeutic Enzymes Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 78. Sanofi Therapeutic Enzymes Product
Table 79. Sanofi Recent Development
Table 80. BioMarin Corporation Information
Table 81. BioMarin Description and Business Overview
Table 82. BioMarin Therapeutic Enzymes Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 83. BioMarin Therapeutic Enzymes Product
Table 84. BioMarin Recent Development
Table 85. AbbVie Corporation Information
Table 86. AbbVie Description and Business Overview
Table 87. AbbVie Therapeutic Enzymes Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 88. AbbVie Therapeutic Enzymes Product
Table 89. AbbVie Recent Development
Table 90. Shire Corporation Information
Table 91. Shire Description and Business Overview
Table 92. Shire Therapeutic Enzymes Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 93. Shire Therapeutic Enzymes Product
Table 94. Shire Recent Development
Table 95. Alexion Corporation Information
Table 96. Alexion Description and Business Overview
Table 97. Alexion Therapeutic Enzymes Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 98. Alexion Therapeutic Enzymes Product
Table 99. Alexion Recent Development
Table 100. Horizon Pharma Corporation Information
Table 101. Horizon Pharma Description and Business Overview
Table 102. Horizon Pharma Therapeutic Enzymes Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 103. Horizon Pharma Therapeutic Enzymes Product
Table 104. Horizon Pharma Recent Development
Table 105. Allergan Corporation Information
Table 106. Allergan Description and Business Overview
Table 107. Allergan Therapeutic Enzymes Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 108. Allergan Therapeutic Enzymes Product
Table 109. Allergan Recent Development
Table 110. Johnson & Johnson Corporation Information
Table 111. Johnson & Johnson Therapeutic Enzymes Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 112. Johnson & Johnson Description and Business Overview
Table 113. Johnson & Johnson Therapeutic Enzymes Product
Table 114. Johnson & Johnson Recent Development
Table 115. Recordati Rare Diseases Corporation Information
Table 116. Recordati Rare Diseases Therapeutic Enzymes Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 117. Recordati Rare Diseases Description and Business Overview
Table 118. Recordati Rare Diseases Therapeutic Enzymes Product
Table 119. Recordati Rare Diseases Recent Development
Table 120. Pfizer Corporation Information
Table 121. Pfizer Description and Business Overview
Table 122. Pfizer Therapeutic Enzymes Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 123. Pfizer Therapeutic Enzymes Product
Table 124. Pfizer Recent Development
Table 125. Vivus Corporation Information
Table 126. Vivus Description and Business Overview
Table 127. Vivus Therapeutic Enzymes Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 128. Vivus Therapeutic Enzymes Product
Table 129. Vivus Recent Development
Table 130. Digestive Care Corporation Information
Table 131. Digestive Care Description and Business Overview
Table 132. Digestive Care Therapeutic Enzymes Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 133. Digestive Care Therapeutic Enzymes Product
Table 134. Digestive Care Recent Development
Table 135. Leadiant Biosciences Corporation Information
Table 136. Leadiant Biosciences Description and Business Overview
Table 137. Leadiant Biosciences Therapeutic Enzymes Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 138. Leadiant Biosciences Therapeutic Enzymes Product
Table 139. Leadiant Biosciences Recent Development
Table 140. Production Base and Market Concentration Rate of Raw Material
Table 141. Key Suppliers of Raw Materials
Table 142. Therapeutic Enzymes Distributors List
Table 143. Therapeutic Enzymes Customers List
Table 144. Therapeutic Enzymes Market Key Trends
Table 145. Therapeutic Enzymes Key Opportunities and Drivers
Table 146. Therapeutic Enzymes Market Challenges
Table 147. Research Programs/Design for This Report
Table 148. Key Data Information from Secondary Sources
Table 149. Key Data Information from Primary Sources
List of Figures
Figure 1. Therapeutic Enzymes Product Picture
Figure 2. Global Therapeutic Enzymes Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Therapeutic Enzymes Market Share by Application in 2020 & 2026
Figure 6. Gaucher Disease Examples
Figure 7. MPS Disease Examples
Figure 8. Gastrointestinal Diseases Examples
Figure 9. Others Examples
Figure 10. Global Therapeutic Enzymes Sales (K Units) Growth Rate (2015-2026)
Figure 11. Global Therapeutic Enzymes Revenue (US$ Million) Growth Rate (2015-2026)
Figure 12. Global Therapeutic Enzymes Price Trends Growth Rate (2015-2026) (USD/Unit)
Figure 13. Global Therapeutic Enzymes Revenue Market Share by Region: 2015 VS 2020
Figure 14. Global Therapeutic Enzymes Revenue Market Share by Region: 2021 VS 2026
Figure 15. United States Therapeutic Enzymes Revenue (Million USD) Growth Rate (2015-2026)
Figure 16. United States Therapeutic Enzymes Sales (K Units) Growth Rate (2015-2026)
Figure 17. Europe Therapeutic Enzymes Revenue (Million USD) Growth Rate (2015-2026)
Figure 18. Europe Therapeutic Enzymes Sales (Million USD) Growth Rate (2015-2026)
Figure 19. China Therapeutic Enzymes Revenue (Million USD) Growth Rate (2015-2026)
Figure 20. China Therapeutic Enzymes Sales (Million USD) and Growth Rate (2015-2026)
Figure 21. Japan Therapeutic Enzymes Revenue (Million USD) Growth Rate (2015-2026)
Figure 22. Japan Therapeutic Enzymes Sales (Million USD) Growth Rate (2015-2026)
Figure 23. Southeast Asia Therapeutic Enzymes Revenue (Million USD) Growth Rate (2015-2026)
Figure 24. Southeast Asia Therapeutic Enzymes Sales (Million USD) Growth Rate (2015-2026)
Figure 25. India Therapeutic Enzymes Revenue (Million USD) Growth Rate (2015-2026)
Figure 26. India Therapeutic Enzymes Sales (Million USD) Growth Rate (2015-2026)
Figure 27. Global 5 Largest Therapeutic Enzymes Players Market Share by Revenue in Therapeutic Enzymes 2015 & 2019
Figure 28. Therapeutic Enzymes Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 29. Global Therapeutic Enzymes Revenue Share by Type (2015-2020)
Figure 30. Global Therapeutic Enzymes Revenue Growth Rate by Type in 2015 & 2019
Figure 31. Global Therapeutic Enzymes Revenue Share by Application (2015-2020)
Figure 32. Global Therapeutic Enzymes Revenue Growth Rate by Application in 2015 & 2019
Figure 33. United States Therapeutic Enzymes Sales Market Share by Type in 2019
Figure 34. United States Therapeutic Enzymes Sales Market Share by Type in 2019
Figure 35. Europe Therapeutic Enzymes Sales Market Share by Company in 2019
Figure 36. Europe Therapeutic Enzymes Sales Market Share by Type in 2019
Figure 37. Europe Therapeutic Enzymes Sales Market Share by Application in 2019
Figure 38. China Therapeutic Enzymes Sales Market Share by Company in 2019
Figure 39. China Therapeutic Enzymes Sales Market Share by Type in 2019
Figure 40. China Therapeutic Enzymes Sales Market Share by Application in 2019
Figure 41. Japan Therapeutic Enzymes Sales Market Share by Company in 2019
Figure 42. Japan Therapeutic Enzymes Sales Market Share by Type in 2019
Figure 43. Japan Therapeutic Enzymes Sales Market Share by Application in 2019
Figure 44. Southeast Asia Therapeutic Enzymes Sales Market Share by Company in 2019
Figure 45. Southeast Asia Therapeutic Enzymes Sales Market Share by Type in 2019
Figure 46. Southeast Asia Therapeutic Enzymes Sales Market Share by Application in 2019
Figure 47. India Therapeutic Enzymes Sales Market Share by Company in 2019
Figure 48. India Therapeutic Enzymes Sales Market Share by Type in 2019
Figure 49. India Therapeutic Enzymes Sales Market Share by Application in 2019
Figure 50. Key Raw Materials Price Trend
Figure 51. Manufacturing Cost Structure of Therapeutic Enzymes
Figure 52. Manufacturing Process Analysis of Therapeutic Enzymes
Figure 53. Therapeutic Enzymes Industrial Chain Analysis
Figure 54. Channels of Distribution
Figure 55. Distributors Profiles
Figure 56. Porter's Five Forces Analysis
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed
バイオ燃料酵素の世界市場レポート2020 Biofuels are the renewable and sustainable source of fuels which are mainly formed by waste plant and animal matter. Biofuel enzymes are biological catalysts which alter and speed up the ongoing reactions and increases productivity, performance and environmental gains in the biofuels. Biofuel enzyme…- タンパク質加水分解酵素の世界市場レポート2020 Market Analysis and Insights: Global Protein Hydrolysate Enzymes Market The global Protein Hydrolysate Enzymes market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. Global Protein Hydrolysate Enzymes Scope and Market Size The global…
- ジュース加工酵素の世界市場レポート2020 Enzyme is a macromolecular protein substance produced by living cells.It has significant effects on improving juice juice yield and clarity in juice processing and production, inhibiting browning of juice and debittering of juice. North America is the largest consumption of enzymes used in juices, w…
- 医療用特殊酵素の世界市場レポート2020 Medical Specialty Enzymes contains the enzymes used for pharmaceutical and diagnostic applications. Amano Enzymes was the global greatest company in Medical Specialty Enzymes industry, with the revenue market Share of 13% in 2018, followed by Sekisui, Novozymes, Roche CustomBiotech, BBI Solutions, A…
- 閉塞性睡眠時無呼吸治療装置の世界市場レポート2020 Obstructive Sleep Apnea Therapeutic Device is used to treat Obstructive Sleep Apnea. This kind of disease is to point to adult every night commonly the period of 7 hours of morpheus, attack times reaches 30 times above, when each attack, breath of mouth, nose stops circulating to reach 10 seconds or…